Metys Pharmaceuticals Competitors and Similar CompaniesClear all

Metys Pharmaceuticals's competitors and similar companies include Mersana Therapeutics, Seagen, Dendreon and Gliknik.

	Metys Pharmaceuticals Metys Pharmaceuticals is a company that provides treatment for chemotherapy-induced peripheral neuropathy, a side effect of several cancer treatments.	Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.	Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.	Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy.	Gliknik Gliknik is a biopharmaceutical company creating therapies for people living with cancer and immune disorders.
Founding Date	Founding Date 2013	Founding Date 2005	Founding Date 1998	Founding Date 1992	Founding Date 2007
Type	Type Private	Type Public	Type Subsidiary	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy
Locations	Locations Basel, CH HQ Basel, CH	Locations Cambridge, US HQ	Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more	Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US	Locations Baltimore, US HQ
Employees	Employees 2	Employees 11033% increase	Employees 3,25622% increase	Employees 6131% decrease	Employees 9
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $40.5m (FY, 2024)	Revenue (est.) $2b (FY, 2022)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income N/A	Net income ($69.2m) (FY, 2024)	Net income ($610.3m) (FY, 2022)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 219.5m	Total funding raised $ 164m	Total funding raised N/A	Total funding raised $ 65.1m